rapidli
becom
pandem
worldwid
therefor
effect
vaccin
urgent
need
recent
messeng
rna
mrna
emerg
promis
platform
vaccin
systemat
investig
untransl
region
utr
mrna
order
enhanc
protein
product
comprehens
analysi
endogen
gene
express
de
novo
design
utr
identifi
optim
combin
utr
term
nasar
five
tenfold
effici
test
endogen
utr
importantli
nasar
mrna
deliv
lipidderiv
nanoparticl
show
dramat
express
potenti
antigen
vitro
vivo
nasar
mrna
merit
develop
altern
vaccin
authorfund
right
reserv
reus
allow
without
permiss
novel
coronaviru
caus
global
pandem
lead
confirm
case
death
april
share
sequenc
ident
sarscov
infect
host
cell
receptor
angiotensinconvert
enzym
counteract
sever
viral
infect
wide
varieti
therapeut
preclin
clinic
studi
current
fdaapprov
treatment
infect
vaccin
effect
strategi
prevent
viral
infect
larg
popul
differ
type
vaccin
mrna
dna
recombin
proteinbas
antigen
current
clinic
trial
among
agent
mrnabas
vaccin
candid
first
enter
clinic
trial
fast
process
develop
manufactur
mrna
express
antigen
effect
mrna
requir
sever
essenti
compon
includ
cap
untransl
region
utr
antigenencod
sequenc
untransl
region
utr
polyadenyl
tail
among
compon
utr
utr
uniqu
regul
protein
translat
design
select
utr
utr
critic
import
ensur
suffici
product
antigen
efficaci
vaccin
host
therefor
systemat
explor
utr
may
provid
broad
applic
mrna
vaccin
respons
emerg
pathogen
previou
studi
util
mani
utr
endogen
gene
protein
express
exampl
utr
human
cytochrom
alpha
polypeptid
cyba
outperform
sever
utr
protein
express
utr
alpha
globin
mrna
enabl
higher
translat
effici
beta
globin
mrna
cell
altern
utr
design
via
de
novo
method
recent
studi
report
seri
consist
nucleotid
nt
also
deep
learn
method
appli
screen
analyz
larg
set
base
signific
advanc
hypothes
integr
endogen
utr
de
novo
design
may
superior
approach
utr
engin
facilit
develop
vaccin
fig
result
prove
concept
approach
significantli
increas
protein
product
compar
utr
report
literatur
lastli
seri
potenti
antigen
visual
via
fluoresc
imag
cell
anim
model
may
serv
vaccin
candid
clinic
trial
figur
schemat
illustr
mrna
engin
utr
utr
mrna
comprehens
modul
base
analysi
endogen
gene
de
novo
design
order
enrich
protein
product
express
antigen
potenti
vaccin
screen
endogen
utr
mammalian
cell
util
bioinformat
analysi
global
gene
express
start
point
previous
averag
halflif
h
translat
rate
constant
protein
copi
number
mrna
correspond
protein
quantifi
mammalian
cell
accord
data
calcul
translat
capac
per
mrna
molecul
use
follow
equat
averag
halflif
h
translat
rate
constant
protein
copi
number
protein
length
amino
acid
translat
capac
per
mrna
molecul
total
amino
acidsmrna
supplementari
tabl
result
indic
number
amino
acid
produc
singl
mrna
halflif
mrna
murin
gene
found
possess
highest
translat
capac
per
mrna
molecul
housekeep
gene
encod
one
compon
ribosom
subunit
two
proteincod
transcript
exist
murin
gene
name
two
transcript
differ
utr
share
utr
supplementari
tabl
supplementari
tabl
therefor
gener
two
mrna
util
utr
respect
two
utr
found
put
termin
oligopyrimidin
top
motif
consist
cluster
pyrimidin
c
u
report
neg
regul
mrna
translat
supplementari
tabl
subsequ
remov
top
motif
utr
construct
two
addit
utr
mrna
encod
firefli
luciferas
synthes
utr
deliv
cell
use
lipofectamin
control
utr
includ
cyba
utr
name
cyba
alpha
globin
utr
name
ag
modifi
alpha
globin
utr
agg
complet
kozak
sequenc
without
utr
utr
better
fig
remov
put
top
motif
moder
improv
express
without
top
motif
increas
rel
luciferas
activ
compar
two
cell
line
compar
cyba
agg
two
best
control
fig
next
compar
utr
three
altern
utr
two
utr
obtain
mrna
transferrin
tf
aat
two
abund
human
plasma
protein
anoth
utr
hepat
c
viral
rna
hcv
report
retain
recycl
subunit
ribosom
translat
termin
stop
codon
acceler
reiniti
translat
construct
utr
utr
shown
fig
utr
display
similar
effect
luciferas
express
addit
replac
anoth
unstructur
utr
length
significantli
decreas
protein
express
supplementari
tabl
supplementari
fig
sinc
length
utr
consider
shorter
utr
aat
tf
hcv
utr
use
follow
studi
besid
util
utr
deriv
endogen
gene
one
altern
approach
design
mrna
utr
via
de
novo
method
wide
appli
protein
engin
process
de
novo
design
utr
sever
gener
principl
consid
exampl
kozak
sequenc
gccacc
locat
directli
upstream
translat
start
codon
aug
includ
conserv
sequenc
among
mani
mammalian
mrna
accur
start
codon
recognit
second
aug
within
utr
exclud
avoid
altern
translat
initi
mutat
amino
acid
sequenc
third
secondari
structur
may
minim
reduc
energi
barrier
smooth
scan
translat
initi
complex
along
utr
base
knowledg
literatur
design
utr
differ
length
minim
secondari
structur
model
rnafold
wellestablish
comput
tool
predict
rna
secondari
structur
supplementari
fig
supplementari
tabl
prepar
mrna
evalu
luciferas
express
mention
result
show
rel
luciferas
activ
increas
utr
length
peak
fig
increas
length
lower
luciferas
express
therefor
use
optim
length
subsequ
design
addit
length
nucleotid
composit
c
g
u
may
import
factor
utr
gener
high
gc
content
commonli
associ
increas
structur
complex
g
base
pair
c
u
induc
format
secondari
structur
increas
u
content
may
introduc
addit
chemic
modifi
nucleotid
utr
modifi
u
pseudouridin
use
mrna
synthesi
understand
effect
nucleotid
composit
perform
nucleotid
composit
analysi
design
seri
utr
adjust
nucleotid
composit
minim
number
g
c
respect
due
transcript
start
site
determin
promot
sequenc
gg
use
kozak
sequenc
gccacc
utr
also
built
avoid
secondari
structur
supplementari
fig
therebi
minim
impact
structur
translat
initi
shown
fig
decreas
rel
luciferas
activ
observ
less
g
amount
c
u
constant
vs
vs
g
u
minim
increas
c
decreas
content
show
moder
decreas
luciferas
express
vs
hold
g
content
minim
inclus
u
boost
rel
luciferas
activ
vs
vs
vs
moreov
utr
acu
outperform
consist
mostli
ac
ag
suggest
import
u
utr
consequ
two
construct
high
u
content
select
studi
microrna
previous
consid
mainli
target
utr
mrna
gene
regul
howev
recent
data
show
mirna
also
interf
ribosom
scan
bind
target
site
within
utr
henc
examin
possibl
mirna
target
site
within
use
predict
tool
avail
mirdb
predict
exhibit
contain
mirna
target
site
supplementari
tabl
adjust
order
nucleotid
creat
maintain
nucleotid
composit
minim
secondari
structur
interestingli
show
slightli
increas
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
express
less
activ
fig
base
result
select
lead
utr
utr
hep
cell
c
rel
luciferas
activ
remov
mirna
target
site
utr
remov
mirna
bind
site
respect
rel
luciferas
activ
normal
cyba
data
present
mean
sd
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
next
studi
effect
function
motif
integr
lead
utr
previou
studi
report
abund
cisregulatori
element
exist
mrna
utr
modul
protein
express
function
motif
rna
bind
protein
rbp
specif
rbp
abl
bind
cognat
motif
within
mrna
utr
enhanc
protein
express
variou
mechan
one
rbp
shown
enabl
cytoplasm
polyadenyl
mrna
upregul
protein
express
bind
target
motif
call
qki
respons
element
qre
utr
two
qre
sequenc
obtain
previou
report
name
anoth
rbp
hur
believ
stabil
target
transcript
bind
cognat
motif
call
aurich
element
eukaryot
cell
one
sequenc
obtain
human
mrna
utr
besid
eukaryot
mrna
sindbi
viru
sinv
evolv
util
part
viral
utr
recruit
hur
induc
potent
stabil
viral
rna
genom
sinv
rna
region
respons
hur
bind
includ
repeat
sequenc
element
urich
element
togeth
name
obtain
addit
ribosom
bind
fragment
two
intern
ribosom
entri
site
iress
encephalomyocard
viru
emcv
footandmouth
diseas
viru
fmdv
select
two
fragment
possess
high
bind
affin
ribosom
subunit
potenti
retain
recycl
subunit
effici
translat
reiniti
base
literatur
find
prepar
mrna
transcript
integr
follow
element
utr
emcv
fmdv
supplementari
tabl
identifi
prefer
function
motif
result
cell
fig
comprehens
utr
engin
optim
utr
identifi
utr
plu
function
motif
utr
name
nasar
sever
round
design
valid
utr
compar
nasar
start
point
endogen
gene
togeth
two
addit
control
utr
literatur
nasar
potent
better
cyba
agg
superior
cell
line
primari
cell
fig
supplementari
fig
result
demonstr
concept
integr
endogen
utr
de
novo
design
effici
strategi
utr
design
rel
luciferas
activ
normal
data
present
mean
sd
statist
signific
b
analyz
twotail
student
ttest
p
p
p
ns
signific
given
potent
activ
nasar
mrna
urgent
demand
vaccin
aim
creat
nasar
mrna
encod
antigen
accord
previou
studi
sarscov
structur
spike
nucleocapsid
n
protein
regard
domin
antigen
elicit
neutral
antibodi
sarscov
patient
explor
vaccin
candid
receptor
bind
domain
rbd
protein
respons
viral
entri
also
util
vaccin
develop
membran
protein
contain
epitop
addit
envelop
e
protein
interact
indispens
assembl
viral
particl
therefor
five
nasar
mrna
prepar
express
rbd
n
e
protein
vaccin
candid
sinc
antibodi
develop
five
potenti
antigen
instal
flag
tag
rbd
and
protein
vsvg
tag
n
e
protein
order
detect
express
confirm
effect
utr
antigen
express
use
nasar
mrna
vaccin
three
addit
mrna
synthes
use
code
sequenc
rbd
control
utr
cyba
nasar
deliveri
three
mrna
cell
use
previous
develop
lipid
likenanoparticl
rbd
express
analyz
elisa
nasar
enabl
antigen
express
cyba
fig
consist
luciferas
express
result
fig
nasar
mrna
encod
five
antigen
deliv
cell
separ
observ
obviou
express
antigen
immunostain
fig
supplementari
fig
base
encourag
cell
result
perform
intramuscular
im
inject
wide
use
administr
rout
vaccin
nasar
mrna
similar
vitro
result
nasar
potent
cyba
luciferas
express
deliv
nanoparticl
supplementari
fig
moreov
nanoparticl
induc
luciferas
activ
nanoparticl
fdaapprov
deliveri
vehicl
formul
nasar
mrna
fig
lastli
nasar
mrna
encod
either
rbd
protein
formul
inject
intramuscularli
hind
leg
mice
confoc
microscopi
imag
mous
tissu
immunostain
confirm
express
antigen
fig
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
figur
nasar
mrna
encod
potenti
antigen
rel
rbd
antigen
level
cell
quantifi
elisa
b
fluoresc
microscopi
imag
rbd
antigen
cell
scale
bar
c
quantif
luciferas
express
vivo
im
inject
mice
luciferas
luciferas
mrna
confoc
microscopi
imag
rbd
antigen
express
mous
muscl
tissu
im
inject
scale
bar
data
present
mean
sd
statist
signific
c
analyz
twotail
student
ttest
p
p
studi
describ
ration
engin
approach
enhanc
protein
product
use
mrna
bioinformat
analysi
modif
endogen
utr
utr
follow
de
novo
design
optim
effect
nasar
utr
identifi
enabl
strong
express
multipl
potenti
antigen
vitro
vivo
base
studi
sever
criteria
consid
design
mrna
utr
regard
utr
length
critic
optim
sequenc
test
work
exceed
free
certain
regulatori
element
eg
top
motif
secondari
structur
upstream
open
read
frame
microrna
bind
site
term
utr
secondari
structur
may
benefit
protein
product
plausibl
explan
structur
utr
might
prevent
ribosom
skip
stop
codon
reach
mrna
end
trigger
nonstop
mrna
decay
nsd
long
utr
length
necessarili
provid
addit
translat
benefit
long
utr
typic
contain
mixtur
posit
neg
cisregulatori
element
although
challeng
obtain
long
endogen
utr
posit
element
specif
posit
cisregulatori
motif
utr
may
use
improv
mrna
translat
hur
bind
motif
ad
utr
enhanc
protein
express
consist
observ
natur
context
indic
certain
posit
cisregulatori
element
may
use
import
utr
compon
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
order
cope
current
pandem
nasar
mrna
appli
encod
variou
antigen
importantli
formul
nasar
fluc
mrna
much
effici
fdaapprov
deliveri
system
enabl
us
combin
strength
nasar
mrna
nanoparticl
maxim
express
antigen
overal
work
provid
proofofconcept
studi
develop
mrna
vaccin
candid
may
conduc
clinic
translat
optimem
reduc
serum
medium
purchas
thermo
fisher
scientif
cell
cultur
plate
luminesc
assay
plate
obtain
corn
purchas
medkoo
dope
purchas
avanti
polar
lipid
cholesterol
obtain
sigmaaldrich
highfidel
pcr
kit
purchas
neb
de
novo
design
utr
utr
design
de
novo
use
antarna
http
rnainformatikunifreiburgd
predefin
nucleotid
composit
sequenc
constrain
minim
secondari
structur
structur
constrain
gu
base
pair
permit
secondari
structur
output
sequenc
confirm
rnafold
http
rnatbiunivieacatcgibinrnawebsuiternafoldcgi
sequenc
undesir
secondari
structur
discard
microrna
bind
site
within
utr
predict
use
custom
predict
tool
microrna
databas
mirdb
http
mirdborg
due
minimum
size
limit
mrna
target
submiss
full
utr
first
nucleotid
firefli
luciferas
code
region
use
input
sequenc
sequenc
necessari
vitro
transcript
mrna
includ
promot
utr
code
sequenc
utr
clone
vector
use
repliqa
hifi
assembl
mix
quantabio
transform
compet
e
coli
neb
chemic
transform
transform
e
coli
allow
grow
lb
broth
miller
plate
agar
carbenicillin
teknova
individu
coloni
inocul
outgrown
lb
broth
liquid
medium
miller
contain
carbenicillin
overnight
vigor
shake
rpm
plasmid
extract
use
qiaprep
spin
miniprep
kit
qiagen
concentr
measur
nanodrop
spectrophotomet
thermo
region
interest
plasmid
promot
utr
confirm
sanger
sequenc
mrna
synthesi
mrna
transcript
synthes
vitro
transcript
use
protocol
modifi
previou
public
briefli
dna
templat
synthes
pcr
amplif
correspond
plasmid
use
forward
primer
revers
primer
contain
end
dna
templat
purifi
qiaquick
pcr
purif
kit
qiagen
examin
agaros
gel
electrophoresi
mrna
synthes
vitro
transcript
substitut
utp
trilink
use
ampliscrib
transcript
kit
lucigen
follow
manufactur
instruct
purifi
rna
clean
concentr
zymo
cap
mrna
conduct
use
vaccinia
cap
system
neb
cap
neb
follow
anoth
purif
rna
clean
concentr
zymo
measur
concentr
nanodrop
spectrophotomet
thermo
mrna
dilut
desir
concentr
te
aliquot
store
futur
use
cell
cultur
eagl
minimum
essenti
medium
corn
fetal
bovin
serum
fb
dulbecco
modifi
eagl
medium
corn
fb
respect
cell
seed
densiti
cellswel
white
flatbottom
plate
costar
follow
overnight
incub
mrna
thaw
ice
denatur
follow
incub
room
temperatur
lipofectamin
thermo
use
transfect
perform
accord
manufactur
instruct
nanoparticl
use
mrna
formul
use
lipid
dope
cholesterol
molar
ratio
report
cell
well
treat
ng
per
well
firefli
luciferas
mrna
luminesc
activ
determin
cytat
cell
imag
multimod
reader
biotek
use
brightglo
luciferas
assay
kit
promega
quantif
rbd
level
elisa
cell
seed
well
plate
grew
overnight
cell
treat
ng
per
well
mrna
encod
rbd
antigen
use
nanoparticl
mention
overnight
incub
cell
lyse
well
cell
lysi
retriev
centrifug
ezview
red
antiflag
affin
gel
use
concentr
flagtag
rbd
pellet
follow
manufactur
protocol
rbd
elut
glycin
hcl
ph
dilut
time
coat
immunopl
thermonunc
block
primari
rabbit
antiflag
antibodi
abcam
dilut
ad
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
follow
incub
hrplink
antirabbit
igg
cell
signal
read
obtain
cytat
cell
imag
multimod
reader
biotek
immunostain
microscopi
imag
cell
grown
overnight
cover
slide
place
plate
nanoparticl
formul
mrna
encod
antigen
rbd
n
e
protein
describ
six
hour
treatment
cell
wash
phosphat
buffer
salin
pb
fix
formalin
follow
permeabil
stain
conduct
use
primari
rabbit
antiflag
antibodi
abcam
dilut
fitclink
secondari
goat
antirabbit
polyclon
antibodi
abcam
dilut
nucleu
stain
hoechst
thermo
seal
slide
imag
taken
nikon
eclips
ti
invert
fluoresc
phase
contrast
microscop
nisel
br
imag
softwar
version
mous
studi
approv
institut
anim
care
use
committe
ohio
state
univers
compli
local
state
feder
regul
mrna
encod
firefli
luciferas
formul
concentr
mgml
use
nanoparticlesand
dialyz
three
mice
per
group
inject
intramuscularli
mrna
per
leg
leg
six
hour
inject
mice
imag
use
xenogen
ivi
spectrum
vivo
imag
system
calip
mrna
encod
antigen
rbd
formul
nanoparticl
mgml
mgml
respect
formul
nanoparticl
dialyz
formul
inject
intramuscularli
rbdencod
mrna
sencod
mrna
mice
euthan
six
hour
inject
muscl
tissu
inject
site
harvest
incub
paraformaldehyd
overnight
follow
sucros
incub
overnight
tissu
section
use
cryotom
e
cryostat
thermoshandon
fix
use
aceton
subsequ
stain
procedur
stain
cell
imag
taken
nikon
live
cell
confoc
microscop
nisel
br
imag
softwar
version
data
analysi
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
data
analysi
conduct
prism
graphpad
ttest
twotail
p
p
p
p
consid
statist
signific
p
valu
specif
statist
method
shown
figur
legend
